Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 625.00 | 320.09 | 719.00 | 736.00 | 0.9769 | 0.9615 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 625.00 | 320.09 | 816.00 | 736.00 | 1.1087 | 1.1794 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 625.00 | 320.09 | 1095.00 | 736.00 | 1.4878 | 1.7840 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 625.00 | 320.09 | 858.00 | 736.00 | 1.1658 | 1.2724 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 625.00 | 320.09 | 424.00 | 736.00 | 0.5761 | 0.2637 |
| BT-20 | Linsitinib | 10 | uM | 9 | 625.00 | 320.09 | 532.00 | 736.00 | 0.7228 | 0.5264 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 793.00 | 736.00 | 1.0774 | 1.1281 | |
| BT-20 | Lapatinib | 1 | uM | 9 | 625.00 | 320.09 | 709.00 | 736.00 | 0.9633 | 0.9387 |
| BT-20 | Lapatinib | 10 | uM | 9 | 625.00 | 320.09 | 257.00 | 736.00 | 0.3492 | -0.1670 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 940.00 | 736.00 | 1.2772 | 1.4518 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 625.00 | 320.09 | 794.00 | 736.00 | 1.0788 | 1.1304 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 790.00 | 736.00 | 1.0734 | 1.1214 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 625.00 | 320.09 | 251.00 | 736.00 | 0.3410 | -0.1833 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 708.00 | 736.00 | 0.9620 | 0.9365 | |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1571.00 | 1754.88 | 0.8952 | 0.8435 | |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1839.00 | 1754.88 | 1.0479 | 1.0701 | |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 1801.00 | 1754.88 | 1.0263 | 1.0386 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 1250.00 | 684.27 | 1806.00 | 1754.88 | 1.0291 | 1.0427 |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 1250.00 | 684.27 | 1732.00 | 1754.88 | 0.9870 | 0.9808 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1656.00 | 1754.88 | 0.9437 | 0.9164 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 684.27 | 909.00 | 1754.88 | 0.5180 | 0.2325 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 1928.00 | 1754.88 | 1.0987 | 1.1434 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 1250.00 | 684.27 | 2058.00 | 1754.88 | 1.1727 | 1.2488 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 2060.00 | 1754.88 | 1.1739 | 1.2505 | |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 1250.00 | 684.27 | 576.00 | 1754.88 | 0.3282 | -0.1191 |